ERO1A, which plays a key role in protein synthesis, is an oncogenic promoter of NSCLC and may promote NSCLC development by regulating cell cycle-associated molecules, such as cyclin D1 and CDK6 27. Here, CDK6 is linked to non-small cell lung carcinoma.